These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 27351426)

  • 1. Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model.
    Pattni BS; Nagelli SG; Aryasomayajula B; Deshpande PP; Kulkarni A; Hartner WC; Thakur G; Degterev A; Torchilin VP
    Pharm Res; 2016 Oct; 33(10):2540-51. PubMed ID: 27351426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination Nanopreparations of a Novel Proapoptotic Drug - NCL-240, TRAIL and siRNA.
    Riehle R; Pattni B; Jhaveri A; Kulkarni A; Thakur G; Degterev A; Torchilin V
    Pharm Res; 2016 Jul; 33(7):1587-601. PubMed ID: 26951567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum to: Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model.
    Pattni BS; Nagelli SG; Aryasomayajula B; Deshpande PP; Kulkarni A; Hartner WC; Thakur G; Degterev A; Torchilin VP
    Pharm Res; 2016 Nov; 33(11):2845-2846. PubMed ID: 27599990
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro.
    Sriraman SK; Geraldo V; Luther E; Degterev A; Torchilin V
    J Control Release; 2015 Dec; 220(Pt A):160-168. PubMed ID: 26497930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of co-delivery of paclitaxel and curcumin by transferrin-targeted PEG-PE-based mixed micelles on resistant ovarian cancer in 3-D spheroids and in vivo tumors.
    Sarisozen C; Abouzeid AH; Torchilin VP
    Eur J Pharm Biopharm; 2014 Oct; 88(2):539-50. PubMed ID: 25016976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin-Modified Vitamin-E/Lipid Based Polymeric Micelles for Improved Tumor Targeting and Anticancer Effect of Curcumin.
    Muddineti OS; Kumari P; Ghosh B; Biswas S
    Pharm Res; 2018 Mar; 35(5):97. PubMed ID: 29541866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
    Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
    Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer.
    Deshpande P; Jhaveri A; Pattni B; Biswas S; Torchilin V
    Drug Deliv; 2018 Nov; 25(1):517-532. PubMed ID: 29433357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reversal of multidrug resistance in ovarian carcinoma cells by co-application of tariquidar and paclitaxel in transferrin-targeted polymeric micelles.
    Zou W; Sarisozen C; Torchilin VP
    J Drug Target; 2017 Mar; 25(3):225-234. PubMed ID: 27616277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted transferrin-modified polymeric micelles: enhanced efficacy in vitro and in vivo in ovarian carcinoma.
    Sawant RR; Jhaveri AM; Koshkaryev A; Zhu L; Qureshi F; Torchilin VP
    Mol Pharm; 2014 Feb; 11(2):375-81. PubMed ID: 24325630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transferrin-targeted polymeric micelles co-loaded with curcumin and paclitaxel: efficient killing of paclitaxel-resistant cancer cells.
    Abouzeid AH; Patel NR; Sarisozen C; Torchilin VP
    Pharm Res; 2014 Aug; 31(8):1938-45. PubMed ID: 24522815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DG.
    Pattni BS; Jhaveri A; Dutta I; Baleja JD; Degterev A; Torchilin V
    Int J Pharm; 2017 Oct; 532(1):149-156. PubMed ID: 28844900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma.
    Yuan M; Qiu Y; Zhang L; Gao H; He Q
    Drug Deliv; 2016 May; 23(4):1171-83. PubMed ID: 26036724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-tumoral efficacy of a docetaxel-loaded liposomal drug delivery system modified with transferrin for ovarian cancer.
    Yuan MQ; Zhu F; Lou JY; Yuan WM; Fu L; Liu S; Zhang ZZ; Liu CY; He Q
    Drug Res (Stuttg); 2014 Apr; 64(4):195-202. PubMed ID: 24154938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models.
    Sarisozen C; Dhokai S; Tsikudo EG; Luther E; Rachman IM; Torchilin VP
    Eur J Pharm Biopharm; 2016 Nov; 108():54-67. PubMed ID: 27569031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transferrin-anchored poly(lactide) based micelles to improve anticancer activity of curcumin in hepatic and cervical cancer cell monolayers and 3D spheroids.
    Kumari P; Rompicharla SVK; Muddineti OS; Ghosh B; Biswas S
    Int J Biol Macromol; 2018 Sep; 116():1196-1213. PubMed ID: 29753013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cancer activity of doxorubicin-loaded liposomes co-modified with transferrin and folic acid.
    Sriraman SK; Salzano G; Sarisozen C; Torchilin V
    Eur J Pharm Biopharm; 2016 Aug; 105():40-9. PubMed ID: 27264717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted adriamycin delivery to MXT-B2 metastatic mammary carcinoma cells by transferrin liposomes: effect of adriamycin ADR-to-lipid ratio.
    Lopez-Barcons LA; Polo D; Llorens A; Reig F; Fabra A
    Oncol Rep; 2005 Nov; 14(5):1337-43. PubMed ID: 16211306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma.
    Jhaveri A; Deshpande P; Pattni B; Torchilin V
    J Control Release; 2018 May; 277():89-101. PubMed ID: 29522834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.
    Perche F; Patel NR; Torchilin VP
    J Control Release; 2012 Nov; 164(1):95-102. PubMed ID: 22974689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.